methylprednisolone has been researched along with Dry Eye Syndromes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, EK; Kim, SK; Kim, TI; Lee, JH; Min, K | 1 |
| Byun, YJ; Kim, EK; Kim, SW; Kim, TI; Kwon, SM; Park, WC; Seo, KY | 1 |
| Chauhan, SK; Dana, R; Dastjerdi, MH; Kodati, S; Okanobo, A | 1 |
| Corrales, RM; De Paiva, CS; Farley, WJ; Li, DQ; Pflugfelder, SC; Stern, ME; Villarreal, AL | 1 |
| Corrales, RM; De Paiva, CS; Farley, W; Li, DQ; Pflugfelder, SC; Stern, ME; Villarreal, AL | 1 |
5 other study(ies) available for methylprednisolone and Dry Eye Syndromes
| Article | Year |
|---|---|
Inflammatory cytokine and osmolarity changes in the tears of dry eye patients treated with topical 1% methylprednisolone.
Topics: Adult; Aged; Cytokines; Dry Eye Syndromes; Female; Humans; Male; Methylprednisolone; Middle Aged; Osmolar Concentration; Prospective Studies; Tears | 2014 |
Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.
Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Female; Fluorophotometry; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin-6; Interleukin-8; Male; Methylprednisolone; Middle Aged; Ophthalmic Solutions; Tears; Treatment Outcome | 2012 |
Efficacy of topical blockade of interleukin-1 in experimental dry eye disease.
Topics: Animals; CD11b Antigen; Cyclosporine; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescent Antibody Technique, Indirect; Fluorophotometry; Glucocorticoids; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lymphangiogenesis; Lymphatic Vessels; Methylprednisolone; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Real-Time Polymerase Chain Reaction; Treatment Outcome | 2012 |
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
Topics: Animals; Anti-Inflammatory Agents; Depression, Chemical; Doxycycline; Dry Eye Syndromes; Epithelium, Corneal; Glucocorticoids; Immunohistochemistry; Interleukin-1; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Methylprednisolone; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Models, Animal; p38 Mitogen-Activated Protein Kinases; Permeability; Scopolamine; Tumor Necrosis Factor-alpha | 2006 |
Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline.
Topics: Animals; Anti-Inflammatory Agents; Cornified Envelope Proline-Rich Proteins; Disease Models, Animal; Doxycycline; Dry Eye Syndromes; Epithelium, Corneal; Fluorescent Antibody Technique, Indirect; Membrane Proteins; Methylprednisolone; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Occludin; Organic Chemicals; Permeability; Protein Precursors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transglutaminases | 2006 |